Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Magda Migkou"'
Autor:
Nikolaos Makris, Georgios Georgiopoulos, Aggeliki Laina, Maria-Eirini Tselegkidi, Despoina Fotiou, Nikolaos Kanellias, Evaggelos Eleftherakis-Papaiakovou, Magda Migkou, Eleni-Dimitra Papanagnou, Konstantinos Katogiannis, Ioannis Petropoulos, Hector Anninos, Dimitrios Bampatsias, Eleni Maneta, Elisabeth Samouilidou, Dimitris Nikas, Giorgia Ciliberti, Konstantinos Stellos, Evaggelos Terpos, Maria Gavriatopoulou, Ioannis P Trougakos, Ignatios Ikonomidis, Meletios-Athanasios Dimopoulos, Efstathios Kastritis, Kimon Stamatelopoulos
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 24:643-652
Aim Ubiquitin-Proteasome System (UPS) is of paramount importance regarding the function of the myocardial cell. Consistently, inhibition of this system has been found to affect myocardium in experimental models; yet, the clinical impact of UPS inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bf1af82f11fd9d6aca0cf6f10257ae
https://doi.org/10.1093/ehjci/jeac168
https://doi.org/10.1093/ehjci/jeac168
Autor:
Evdoxia Panou, Leonidas Marinos, Evangelia Piperaki, Magda Migkou, Alexander J Stratigos, Vasiliki Nikolaou
Publikováno v:
Clinical and Experimental Dermatology.
We present an interesting case of a patient with post-kala-azar dermal leishmaniasis (PKDL), encountered in Greece. The man developed PKDL while on treatment with lenalidomide and corticosteroids for multiple myeloma. PKDL is an important neglected t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d936be6217483ddfc7d6c9ef178ec72
https://doi.org/10.1093/ced/llad100
https://doi.org/10.1093/ced/llad100
Autor:
loannis Kostopoulos, loannis Ntanasis-Stathopoulos, Nikolaos Aggelis, Panos Malandrakis, Evangelos Eleftherakis-Papaiakovou, Pantelis Rousakis, Chrysanthi Panteli, Nikolaos Kanelias, Despina Fotiou, Magda Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios-Athanasios Dimopoulos, Evangelos Terpos
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S424-S425
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e96bff57f21500aaf4d7e8ddf412b88a
https://doi.org/10.1016/s2152-2650(22)01626-3
https://doi.org/10.1016/s2152-2650(22)01626-3
Autor:
Ioannis Kostopoulos, Ioannis Ntanasis-Stathopoulos, Nikolaos Aggelis, Panos Malandrakis, Evangelos Eleftherakis-Papaiakovou, Pantelis Rousakis, Chrysanthi Panteli, Nikolaos Kanelias, Despina Fotiou, Magda Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios-Athanasios Dimopoulos, Evangelos Terpos
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08dd8cc3d42a40fbcd19501a37f694e1
https://doi.org/10.1016/s2152-2650(22)01132-6
https://doi.org/10.1016/s2152-2650(22)01132-6
Autor:
Kostas Palamaris, Dimitrios Alexandris, Kostas Stylianou, Ioannis Giatras, Anastasios Stofas, Christina Kaitatzoglou, Magda Migkou, Dimitrios Goutas, Erasmia Psimenou, Eleni Theodoropoulou, Stamatios Theocharis, Nektarios Alevizopoulos, Efstathios Kastritis, Alexandros Gerakis, Harikleia Gakiopoulou
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 16; Pages: 4786
We present a series of twelve patients, bearing a wide range of solid malignancies, who received either PD-L1 or a combination of PD-L1 and CTLA-4 inhibitors. Following immunotherapy administration, they exhibited the clinical signs indicative of ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c90c2be3cc29a96586bc9947f5b3052
https://doi.org/10.3390/jcm11164786
https://doi.org/10.3390/jcm11164786
Autor:
Ioannis Ntanasis-Stathopoulos, N. Kanellias, Ourania E. Tsitsilonis, Meletios-Athanasios Dimopoulos, Efstathios Kastritis, Maria Gavriatopoulou, Magda Migkou, Despoina Fotiou, Kostas Papadimitriou, Chrysanthi Panteli, Aristina Papanota, Panagiotis Malandrakis, Evangelos Terpos, Pantelis Rousakis, Ioannis Kostopoulos, Evangelos Eleftherakis-Papaiakovou
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S297-S298
Context: The apparent heterogeneity of multiple myeloma (MM) necessitates the identification of novel biomarkers with a strong prognostic value. The presence of circulating plasma cells (CPCs) in newly diagnosed patients (NDMM) has been proposed as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4e1db1f8ef8a0ed05867a9f2e57db58
https://doi.org/10.1016/s2152-2650(20)30936-8
https://doi.org/10.1016/s2152-2650(20)30936-8
Autor:
Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Dimitrios Christoulas, Evangelos Bournakis, Evangelos Kostis, Magda Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Christos Papadimitriou, Eleni Efstathiou, Evangelos Terpos
Publikováno v:
American Journal of Hematology. 85:863-867
One hundred and fifty-seven patients undergoing high-dose chemotherapy (HDT) and autologous stem-cell transplantation (ASCT) for hematopoietic malignancies and solid tumors were randomly assigned to receive (Group A) or not (Group B) prophylaxis with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f185751918d2dd2fbdcd435a76b496
https://doi.org/10.1002/ajh.21855
https://doi.org/10.1002/ajh.21855
Publikováno v:
Expert Opinion on Biological Therapy. 9:207-220
The introduction of mAbs has changed the clinical approach to patients with lymphoma and leukemia.To summarize the most significant applications of mAb-based regimens in the treatment of hematological malignancies and explore their possible role in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2e6ac6f464d5a10732341935e8dbf90
https://doi.org/10.1517/14712590802650581
https://doi.org/10.1517/14712590802650581
Autor:
Magda Migkou, Meletios-Athanassios Dimopoulos, Dimitrios Christoulas, Efstathios Kastritis, Maria Gavriatopoulou, Evangelos Terpos
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S30-S32
we are investigating the epigenetic regulation of the pro-apoptotic gene Bim. In contrast to CD9, pyrosequencing analysis showed no DNA methylation of the Bim promoter. Both Western blot and ChIP demonstrated that induced upregulation of Bim upon tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::587f34b8ab5aab08b42d1d05acd93097
https://doi.org/10.1016/s1557-9190(11)70818-6
https://doi.org/10.1016/s1557-9190(11)70818-6